Literature DB >> 26729767

Lymphopenia as a predictor of sarcoidosis in patients with uveitis.

N P Jones1, L Tsierkezou1, N Patton1.   

Abstract

AIMS: To investigate the hypothesis that lymphopenia is an independent predictor of sarcoidosis in new patients presenting with uveitis. PATIENTS AND METHODS: Retrospective case-control study of 112 patients with sarcoidosis-associated uveitis (SAU) against 398 controls with other forms of uveitis.
RESULTS: Of the patients with SAU, 30/112 (26.8%) had significant lymphopenia (<1.0×10(9)/L), compared with 24/398 (6.0%) for other uveitis (p≤0.0001, OR 5.7 (95% CI 3.2 to 10.3)). The mean lymphocyte count for patients with SAU was 1.43 vs 2.04 for other uveitis (p≤0.0001). Logistic regression modelling using diagnosis of SAU as the independent variable identified age, ACE levels and lymphocyte count as independent predictors of SAU. A new patient with uveitis with significant lymphopenia has a risk of sarcoidosis (from this parameter alone) of 31.6%.
CONCLUSIONS: Significant lymphopenia (<1.0×10(9)/L) is an independent predictor of sarcoidosis in new patients presenting with uveitis. We recommend that diagnostic criteria for SAU should be modified to include this phenomenon. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Diagnostic tests/Investigation; Inflammation

Mesh:

Year:  2016        PMID: 26729767     DOI: 10.1136/bjophthalmol-2015-307455

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  Presumed tuberculosis-associated uveitis: rising incidence and widening criteria for diagnosis in a non-endemic area.

Authors:  N Krassas; J Wells; C Bell; M Woodhead; N Jones
Journal:  Eye (Lond)       Date:  2017-08-04       Impact factor: 3.775

Review 2.  Ocular sarcoidosis: new diagnostic modalities and treatment.

Authors:  Sung J Yang; Sherveen Salek; James T Rosenbaum
Journal:  Curr Opin Pulm Med       Date:  2017-09       Impact factor: 3.155

Review 3.  [Sarcoidosis and uveitis : An update].

Authors:  J G Garweg
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

4.  Ocular sarcoidosis prevalence and clinical features in the Northern Ireland population.

Authors:  Gerard Reid; Michael Williams; Marie Compton; Giuliana Silvestri; Clara McAvoy
Journal:  Eye (Lond)       Date:  2021-09-23       Impact factor: 4.456

Review 5.  [Ocular sarcoidosis].

Authors:  C Springer-Wanner; T Brauns
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

6.  Diagnostic value of lymphopaenia and elevated serum ACE in patients with uveitis.

Authors:  Philippine Cotte; Pierre Pradat; Laurent Kodjikian; Yvan Jamilloux; Pascal Seve
Journal:  Br J Ophthalmol       Date:  2020-09-11       Impact factor: 4.638

Review 7.  Sarcoid Uveitis: An Intriguing Challenger.

Authors:  Pia Allegri; Sara Olivari; Federico Rissotto; Roberta Rissotto
Journal:  Medicina (Kaunas)       Date:  2022-07-04       Impact factor: 2.948

8.  Comparison of CD4 Counts with Mycophenolate Mofetil versus Methotrexate from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial.

Authors:  Christina L Kong; Nicole K Kelly; Miel Sundararajan; S R Rathinam; John A Gonzales; Radhika Thundikandy; Rajesh Vedhanayaki; Anuradha Kanakath; Bala Murugan; Thuy Doan; Debra Goldstein; Hassan A Al-Dhibi; Nisha R Acharya
Journal:  Ocul Immunol Inflamm       Date:  2020-08-11       Impact factor: 3.070

9.  Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts.

Authors:  Hok Sreng Te; David M Perlman; Chetan Shenoy; Daniel J Steinberger; Rebecca J Cogswell; Henri Roukoz; Erik J Peterson; Lin Zhang; Tadashi L Allen; Maneesh Bhargava
Journal:  BMC Pulm Med       Date:  2020-06-01       Impact factor: 3.317

Review 10.  Progress in the diagnosis of ocular sarcoidosis.

Authors:  Ghazala A Datoo O'Keefe; Narsing A Rao
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.